Earnings Labs

Great Elm Group, Inc. 7.25% Notes due 2027 (GEGGL)

Q1 2023 Earnings Call· Tue, Nov 15, 2022

$24.45

-0.11%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

-3.67%

1 Week

-5.23%

1 Month

-12.76%

vs S&P

-8.85%

Transcript

Operator

Operator

Good morning. My name is Chris and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Great Elm Group Fiscal 2023 First Quarter Conference Call. [Operator Instructions] Adam Yates, Managing Director. You may begin.

Adam Yates

Analyst

Thank you and good morning, everyone. Thank you for joining us for Great Elm Group's fiscal first quarter 2023 earnings conference call. As a reminder, this conference call is being recorded on Tuesday, November 15, 2022. If you would like to be added to our distribution list, you can e-mail investorrelations@greatelmcap.com or you can sign up for alerts directly on our website, www.greatelmgroup.com. The slide presentation accompanying today's conference call and webcast can be found on our website under Events and Presentations. A link to the webcast is also available on our website as well as in the press release that was disseminated to announce the quarterly results. Today's conference call includes forward-looking statements and we ask that you refer to Great Elm Group's filings with the SEC for important factors that could cause actual results to differ materially from those statements. Great Elm Group does not undertake to update its forward-looking statements unless required by law. In addition, during today's call, management will refer to certain non-GAAP financial measures. Reconciliations to the most comparable financial measures are included in our earnings release. To obtain copies of our SEC filings, please visit Great Elm Group's website under Financial Information and select SEC Filings. Great Elm Group is a diversified holding company that is building a business across two operating verticals investment management and operating companies. In Investment Management, we seek to drive sustainable growth in assets under management across Great Elm Capital Corp.; a publicly traded BDC; Monomoy REIT and other investment vehicles. In operating companies, we manage Great Elm Durable Medical Equipment, DME, a distributor of respiratory care equipment and sleep study services. Hosting the call today is Peter Reed, Great Elm Group's Chief Executive Officer. I will now turn the call over to Peter.

Peter Reed

Analyst

Welcome, everyone and thank you for joining us today. I am joined this afternoon by our President, Adam Kleinman; and our CFO, Brent Pearson. In the first quarter of fiscal 2023, we generated strong growth across both of our operating segments. Investment Management revenues were up nearly 90% year-over-year. Assets under management were up 3% during the quarter to $624 million as of September 30, 2022. Fee-paying AUM grew by 5% during the fiscal first quarter to $428 million. At Monomoy, we maintained a strong backlog of transactions that have the potential to provide further growth. And at GECC, we are focused on prudently deploying rights offering proceeds, both of which are expected to lead to increased AUM and related fees. Yesterday, GECC announced that it launched Great Elm Healthcare Finance with an affiliate of Berkadia Commercial Mortgage, its strategic minority partner, to offer a wide range of capital solutions to U.S.-based health care operators. We believe ongoing initiatives to further diversify GECC's portfolio to generate attractive returns across cycles will enhance growth and as a result, GEG's management fees. Stepping back, we remain focused on our long-term strategy of managing a scalable and diversified portfolio of long-duration permanent capital vehicles that generate fee revenue and we continue to invest in the business to drive sustainable growth. Our diverse investment vehicles are well positioned to deploy capital into attractive credit specialty finance and real estate investments in dislocated markets. As our investment management business continues to scale, growth in AUM will drive increasing management fees and profits, reflecting high incremental margins. A higher interest rate backdrop also bodes well for performance fees which are typically based on excess returns above a fixed rate hurdle. In addition, we maintain a strong and liquid balance sheet enhanced by our recent fixed rate,…

Brent Pearson

Analyst

Thanks, Pete. I'll provide a brief overview and of course, welcome all of you to review our filings in greater detail or to reach out to our team with questions you may have. During the quarter ended September 30, 2022, we reported consolidated revenue of $18.6 million, a net loss of $8.5 million and adjusted EBITDA of $2.7 million. For the same period last year, we reported consolidated revenue of $16.5 million, net income of $0.1 million and adjusted EBITDA of $4.3 million. Great Elm reports the results of each of our two operating segments, including Investment Management and Durable Medical Equipment as well as unallocated general corporate activity. We'll begin the review with investment management. For the fiscal first quarter, Investment Management reported total revenue of $1.9 million compared to $1.0 million during the same period in the prior year. Increase primarily related to the recently acquired management agreement with Monomoy. For the quarter, Investment Management reported a net loss of $6.0 million in comparison to a net loss of $0.1 million in the prior year period. The variance was primarily a function of higher losses on GECC shares. This impact was partially offset by increased dividend income as compared to the prior year period. Adjusted EBITDA was $279,000 in fiscal 2023 1st quarter compared to $140,000 during the same period in the prior year, with higher revenue, partially offset by higher operating expenses. Next, turning to Durable Medical Equipment. For the fiscal first quarter, DME generated $16.7 million in revenue compared to $15.6 million for the same period last year. This increase was driven primarily by organic growth and resupply revenue, a full quarter of contributions from the MedOne acquisition in August 2021 and improved revenue reserves despite ongoing global supply chain issues. Great Elm's DME operations reported…

Operator

Operator

Peter Reed

Analyst

Thank you again for joining us today and we look forward to speaking with you in the future.

Operator

Operator

Ladies and gentlemen, this concludes today's conference call. Thank you for participating and you may now disconnect.